Clinical Trial Update: Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of crizanlizumab on kidney function in patients with chronic kidney disease caused by sickle cell disease has completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Sickle Cell Disease

Drugs mentioned

• ADAKVEO (crizanlizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Sickle Cell Disease (SCD) | Phase 2 | Status: COMPLETED | Results posted: 2024-06-04